These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29496375)

  • 1. Expression of aberrantly spliced oncogenic Ikaros isoforms coupled with clonal IKZF1 deletions and chimeric oncogenes in acute lymphoblastic leukemia.
    Vshyukova V; Valochnik A; Meleshko A
    Blood Cells Mol Dis; 2018 Jul; 71():29-38. PubMed ID: 29496375
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
    J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of targeted RNA sequencing for the analysis of fusion genes, gene mutations, IKZF1 intragenic deletion, and CRLF2 overexpression in acute lymphoblastic leukemia.
    Zhang Z; Jing Y; Chen B; Zhang H; Liu T; Dong S; Zhang L; Yan X; Yang S; Chen L; Lin Y; Ru K
    Int J Lab Hematol; 2024 Aug; 46(4):670-677. PubMed ID: 38553845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
    Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia.
    Fang Q; Zhao X; Li Q; Li Y; Liu K; Tang K; Wang Y; Liu B; Wang M; Xing H; Rao Q; Tian Z; Wang J; Mi Y
    Leuk Lymphoma; 2017 Jan; 58(1):127-137. PubMed ID: 27157479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia.
    Górniak P; Pastorczak A; Zalewska-Szewczyk B; Lejman M; Trelińska J; Chmielewska M; Sokół-Jeżewska A; Kowalczyk J; Szczepanski T; Matysiak M; Kazanowska B; Mlynarski W;
    Leuk Lymphoma; 2014 Sep; 55(9):2174-8. PubMed ID: 24597983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.
    Boer JM; van der Veer A; Rizopoulos D; Fiocco M; Sonneveld E; de Groot-Kruseman HA; Kuiper RP; Hoogerbrugge P; Horstmann M; Zaliova M; Palmi C; Trka J; Fronkova E; Emerenciano M; do Socorro Pombo-de-Oliveira M; Mlynarski W; Szczepanski T; Nebral K; Attarbaschi A; Venn N; Sutton R; Schwab CJ; Enshaei A; Vora A; Stanulla M; Schrappe M; Cazzaniga G; Conter V; Zimmermann M; Moorman AV; Pieters R; den Boer ML
    Leukemia; 2016 Jan; 30(1):32-8. PubMed ID: 26202931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
    Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
    Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKZF1 Gene Deletion in Pediatric Patients Diagnosed with Acute Lymphoblastic Leukemia in Mexico.
    Ayón-Pérez MF; Pimentel-Gutiérrez HJ; Durán-Avelar MJ; Vibanco-Pérez N; Pérez-Peraza VM; Pérez-González ÓA; Barrientos-Ríos R; Santillán-Ávila CF; Zambrano-Zaragoza JF; Agraz-Cibrián JM; Gutiérrez-Franco J; Vázquez-Reyes A
    Cytogenet Genome Res; 2019; 158(1):10-16. PubMed ID: 30974435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Dörge P; Meissner B; Zimmermann M; Möricke A; Schrauder A; Bouquin JP; Schewe D; Harbott J; Teigler-Schlegel A; Ratei R; Ludwig WD; Koehler R; Bartram CR; Schrappe M; Stanulla M; Cario G
    Haematologica; 2013 Mar; 98(3):428-32. PubMed ID: 22875627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic inactivation of Ikaros is a rare event in human T-ALL.
    Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
    Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia.
    Mata-Rocha M; Rangel-López A; Jiménez-Hernández E; Morales-Castillo BA; González-Torres C; Gaytan-Cervantes J; Álvarez-Olmos E; Núñez-Enríquez JC; Fajardo-Gutiérrez A; Martín-Trejo JA; Solís-Labastida KA; Medina-Sansón A; Flores-Lujano J; Sepúlveda-Robles OA; Peñaloza-González JG; Espinoza-Hernández LE; Núñez-Villegas NN; Espinosa-Elizondo RM; Cortés-Herrera B; Torres-Nava JR; Flores-Villegas LV; Merino-Pasaye LE; Bekker-Méndez VC; Velázquez-Aviña MM; Pérez-Saldívar ML; Bautista-Martínez BA; Amador-Sánchez R; González-Avila AI; Jiménez-Morales S; Duarte-Rodríguez DA; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mejía-Aranguré JM
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.
    Lopes BA; Meyer C; Barbosa TC; Zur Stadt U; Horstmann M; Venn NC; Heatley S; White DL; Sutton R; Pombo-de-Oliveira MS; Marschalek R; Emerenciano M
    Oncotarget; 2016 Aug; 7(33):53064-53073. PubMed ID: 27419633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.